Maryland Stem Cell Research Fund

Johns Hopkins, MSCRF, BioCardia treat first patient with CardiAMP in ischemic heart failure trial

Wednesday, March 1, 2017

Johns Hopkins Medicine, the Maryland Stem Cell Research Fund (MSCRF) and BioCardia announced that the first patient has been treated in the pivotal phase III CardiAMP clinical trial of a cell-based therapy for the treatment of ischemic heart failure that develops after a heart attack. The first patient was treated at Johns Hopkins Hospital by a team led by Peter Johnston, M.D., a faculty member in the Department of Medicine and Division of Cardiology, and principal investigator of the trial at Johns Hopkins.

[Read More]